SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is trending following widespread community discussion and speculation regarding its potential inclusion in the S&P 500 index during the upcoming rebalancing. Investors are closely monitoring the announcement while expressing a mix of bullish enthusiasm over the potential for increased institutional demand and skepticism due to recent volatility and profit-taking.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending as traders debate the company's prospects following its partnership with Payward to integrate SoFiUSD and banking rails with Kraken, while simultaneously reacting to the news that SoFi was not included in the S&P 500 rebalancing. Community sentiment remains polarized, with some investors emphasizing long-term growth and analyst upgrades, while others express frustration over share price volatility and ongoing debates about institutional manipulation.

Astera Labs, Inc. provides rack-scale AI infrastructure through purpose-built connectivity solutions. The company offers a range of semiconductor-based connectivity solutions designed to address bandwidth, latency, and reliability challenges in AI and cloud data centers. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs is attracting significant attention as traders anticipate upcoming quarterly earnings, with many discussing the stock's recent volatility and its role in AI infrastructure. The community is split between bullish sentiment driven by strong growth expectations and bearish concerns regarding the stock's high valuation and potential for profit-taking.

Cheniere Energy, Inc. engages in liquefied natural gas (LNG) related businesses. It owns and operates LNG terminals, develops, constructs, and operates liquefaction projects near Corpus Christi, Texas, and at the Sabine Pass LNG terminal. The company was founded by Charif Souki in 1983 and is headquartered in Houston, TX.

Cheniere Energy Inc.

Cheniere Energy is trending as investors weigh its potential for inclusion in the S&P 500 index during the upcoming rebalancing. The community is expressing mixed reactions to the stock's recent price performance in the context of this potential catalyst.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

XCN is trending following its listing on the Upbit exchange, which has triggered a significant increase in trading volume and speculation regarding a potential price recovery. While some community members are optimistic that this development and associated institutional infrastructure plans will drive long-term growth, many remain skeptical, labeling the move a transient pump and maintaining a bearish outlook due to previous failed rallies.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as traders anticipate upcoming company news and potential partnership announcements, particularly in light of scheduled industry presentations and recent hiring for manufacturing scale-up. While bulls remain optimistic about a fundamental re-rating and the company's long-term potential, some investors express frustration over recent stock performance, lack of immediate material announcements, and the ongoing influence of broader market volatility on the sector.

Everpure, Inc. engages in the business of delivering innovative and disruptive data storage, products, and services that enable customers to maximize the value of data. The firm is also involved in the provision of data storage and management with a mission to redefine the storage experience by simplifying how people consume and interact with data. The company was founded by John M. Hayes and John Colgrove in October 2009 and is headquartered in Santa Clara, CA.

Everpure Inc. - Ordinary Shares - Class A

Everpure Inc

Everpure is attracting attention amid market speculation that it is a top candidate for inclusion in the S&P 500. Traders are debating the timing of the potential addition and the stock's long-term growth prospects compared to other potential index candidates.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXTI is experiencing high volatility as traders react to a sharp pullback from recent highs, with many viewing the decline as a profit-taking opportunity rather than a fundamental shift. Discussion remains centered on the company's role as a key supplier of indium phosphide for AI-driven optical networking, though sentiment is split between bullish long-term investors and those concerned about high valuations and sector-wide weakness.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco is facing downward pressure as traders debate its high valuation and the impact of decelerating comparable sales reported for June. While some investors remain bullish on its long-term membership model and defensive strength, others are concerned that the stock's elevated price-to-earnings ratio is unsustainable in the current retail environment.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is facing selling pressure following the announcement of subscription price hikes in the United Kingdom, with traders divided on whether these increases signal continued growth or a risk to subscriber retention. While some investors remain bullish, citing strong fundamentals and the potential for increased revenue, others are expressing frustration over stagnant price action and competition in the streaming space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Heron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -50.00% and -11.17%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Verrica Pharmaceuticals Inc. (VRCA) Reports Q2 Loss, Beats Revenue Estimates

Verrica Pharmaceuticals (VRCA) delivered earnings and revenue surprises of +14.29% and +1.77%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

BioCryst Pharmaceuticals (BCRX) Tops Q2 Earnings and Revenue Estimates

BioCryst (BCRX) delivered earnings and revenue surprises of +114.29% and +18.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for July 15th

BV, RAIL and HRTX have been added to the Zacks Rank #5 (Strong Sell) List on July 15th, 2026.

Why Did FULC, MVIS, HRTX Stocks Plunge To 52-Week Lows Today? 

Equity

The selloff highlighted the risks facing smaller companies operating in biotechnology and emerging technology. 


Why Heron Therapeutics, Inc. (HRTX) Price Target Was Reduced to $4 at H.C. Wainwright?

Why Heron Therapeutics, Inc. (HRTX) Price Target Was Reduced to $4 at H.C. Wainwright...

Heron Therapeutics Q1 Earnings Call Highlights

Heron Therapeutics Q1 Earnings Call Highlights...

Heron Therapeutics (HRTX) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for Heron Therapeutics (HRTX) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Heron Therapeutics (HRTX) Reports Q1 Loss, Lags Revenue Estimates

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -33.33% and -3.91%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Ironwood Pharmaceuticals (IRWD) Tops Q1 Earnings and Revenue Estimates

Ironwood (IRWD) delivered earnings and revenue surprises of +242.86% and +44.26%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

• Reported GAAP EPS of -$0.03 down -50.00% YoY
• Reported revenue of $37.67M up 1.25% YoY

Heron Therapeutics faces significant financial challenges, including increased net losses, adverse patent litigation outcomes, and a notification from Nasdaq regarding non-compliance with minimum bid price requirements for continued listing.

Heron Therapeutics achieved strong growth in acute care net product sales, secured favorable J-code reimbursement for ZYNRELEF, and maintains sufficient liquidity to support operations for at least one year.

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.

Heron Therapeutics Inc

Extremely Bearish Sentiment

The Federal Reserve hasn't raised rates at all in 2026, but hawkish comments from Fed Chair Kevin Warsh at the Jackson Hole symposium have pushed September rate hike odds as high as 66%, a sharp jump from under 40% just a week earlier. How many rate hikes do you expect from the Fed in 2026? Vote and explain your reasoning in the comments.

How many rate hikes do you expect from the Fed in 2026?

Current Price	$0.3439
Prev Close	$0.33
Open	$0.3375
Dividend Yield	0.00%
50-Day Moving Average	$0.4072
Beta	1.44
Avg. Volume	3.11M
PE Ratio	-1.74

52-Week High	$1.58
52-Week Low	$0.2975
Market Capitalization	$62.65M
EPS (Annual)	-$0.1211
Price to Book	10.67
Revenue Per Employee	$1.21M

Feed

News

Sentiment

Earnings

Fundamentals

Info

HRTX Fundamentals